Lymphatic drainage function and its immunological implications: From dendritic cell homing to vaccine design

Seminars in Immunology

Volumn 20, Issue 2, 2008, Pages 147-156

  Swartz, Melody A ^a   Hubbell, Jeffrey A ^a   Reddy, Sai T ^a  

^a EPFL   (Switzerland)

Author keywords

Adjuvant; Biomaterials; Chemotaxis; Complement; Engineering; Flow; Immunotherapy; Lymph node; Lymphatic morphogenesis

Indexed keywords

CANCER VACCINE; DENDRITIC CELL VACCINE; DNA VACCINE; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; PROSTATE SPECIFIC ANTIGEN; PROVENGE;

CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CELL COMMUNICATION; CELL HOMING; CELLULAR IMMUNITY; CHEMOTAXIS; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INNATE IMMUNITY; LYMPH FLOW; LYMPH NODE; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; LYMPHATIC DRAINAGE; LYMPHATIC SYSTEM; LYMPHOID TISSUE; NONHUMAN; PROSTATE CANCER; REVIEW; TISSUE ENGINEERING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL MOVEMENT; DENDRITIC CELLS; EXTRACELLULAR FLUID; HUMANS; LYMPHATIC VESSELS; PROTEIN TRANSPORT; TISSUE ENGINEERING; VACCINES;

EID: 40649090113     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2007.11.007     Document Type: Review

References (107)

1. Angeli V., Ginhoux F., Llodra J., Quemeneur L., Frenette P.S., Skobe M., et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24 2 (2006) 203-215
2. Steinman R.M., and Inaba K. Myeloid dendritic cells. J Leukoc Biol 66 (1999) 205-208
3. Leak L.V. Structure of lymphatic capillaries in lymph formation. Fed Proc 35 8 (1976) 1863-1871
4. Leak L.V. Permeability of lymphatic capillaries. J Cell Biol 50 2 (1971) 300-323
5. Spiegel M., Vesti B., Shore A., Franzeck U.K., Becker F., and Bollinger A. Pressure of lymphatic capillaries in human skin. Am J Phys 262 4 (1992) H1208-H1210
6. Fischer M., Franzeck U.K., Herrig I., Costanzo U., Wen S., Schiesser M., et al. Flow velocity of single lymphatic capillaries in human skin. Am J Phys 39 1 (1996) H358-H363
7. Swartz M.A., Berk D.A., and Jain R.K. Transport in lymphatic capillaries. 1. Macroscopic measurements using residence time distribution theory. Am J Phys 39 1 (1996) H324-H329
8. Schmid-Schonbein G.W. Microlymphatics and lymph flow. Physiol Rev 70 4 (1990) 987-1028
9. Trzewik J., Mallipattu S.K., Artmann G.M., Delano F.A., and Schmid-Schonbein G.W. Evidence for a second valve system in lymphatics: endothelial microvalves. FASEB J 15 (2001) 1711-1717
10. Quick C.M., Venugopal A.M., Gashev A.A., Zawieja D.C., and Stewart R.H. Intrinsic pump-conduit behavior of lymphangions. Am J Phys 292 4 (2007) R1510-R1518
11. von der Weid P.Y., and Zawieja D.C. Lymphatic smooth muscle: the motor unit of lymph drainage. Int J Biochem Cell Biol 36 7 (2004) 1147-1153
12. Zawieja D.C., Davis K.L., Schuster R., Hinds W.M., and Granger H.J. Distribution, propagation, and coordination of contractile activity in lymphatics. Am J Phys 264 4 (1993) H1283-H1291
13. Kaldjian E.P., Gretz J.E., Anderson A.O., Shi Y.H., and Shaw S. Spatial and molecular organization of lymph node T cell cortex: a labyrinthine cavity bounded by an epithelium-like monolayer of fibroblastic reticular cells anchored to basement membrane-like extracellular matrix. Int Immunol 13 10 (2001) 1243-1253
14. Bajenoff M., Egen J.G., Koo L.Y., Laugier J.P., Brau F., Glaichenhaus N., et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 25 6 (2006) 989-1001
15. Sixt M., Kanazawa N., Seig M., Samson T., Roos G., Reinhardt D.P., et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22 1 (2005) 19-29
16. Cyster J.G. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Ann Rev Immunol 23 (2005) 127-159
17. Luther S.A., Tang H.L., Hyman P.L., Farr A.G., and Cyster J.G. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Nat Acad Sci U S A 97 23 (2000) 12694-12699
18. Cyster J.G. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J Exp Med 189 (1999) 447-450
19. Cyster J.G. Chemokines-chemokines and cell migration in secondary lymphoid organs. Science 286 5447 (1999) 2098-2102
20. Luther S.A., Bidgol A., Hargreaves D.C., Schmidt A., Xu Y., Paniyadi J., et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 169 1 (2002) 424-433
21. Bousso P., and Robey E. Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes. Nat Immunol 4 (2003) 579-585
22. Brand C.U., Hunziker T., and Braathen L.R. Isolation of human skin-derived lymph: flow and output of cells following sodium lauryl sulphate-induced contact dermatitis. Arch Dermatol Res 284 3 (1992) 123-126
23. Drake R.E., and Gabel J.C. Effect of outflow pressure on intestinal lymph flow in unanesthetized sheep. Am J Physiol 260 4 Pt 2 (1991) 668-671
24. Bajenoff M., Egen J.G., Qi H., Huang A.Y., Castellino F., and Germain R.N. Highways, byways and breadcrumbs: directing lymphocyte traffic in the lymph node. Trends Immunol 28 8 (2007) 346-352
25. Hirakawa S., Brown L.F., Kodama S., Paavonen K., Alitalo K., and Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109 3 (2007) 1010-1017
26. Rockson S.G. Lymphedema. Am J Med 110 4 (2001) 288-295
27. Ohl L., Mohaupt M., Czeloth N., Hintzen G., Kiafard Z., Zwirner J., et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21 2 (2004) 279-288
28. Ritter U., Wiede F., Mielenz D., Kiafard Z., Zwirner J., and Korner H. Analysis of the CCR7 expression on murine bone marrow-derived and spleen dendritic cells. J Leukoc Biol 76 2 (2004) 472-476
29. Sozzani S., Allavena P., D'Amico G., Luini W., Bianchi G., Kataura M., et al. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 161 3 (1998) 1083-1086
30. Saeki H., Moore A.M., Brown M.J., and Hwang S.T. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 162 5 (1999) 2472-2475
31. Gunn M.D., Kyuwa S., Tam C., Kakiuchi T., Matsuzawa A., Williams L.T., et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 189 3 (1999) 451-460
32. Robbiani D.F., Finch R.A., Jager D., Muller W.A., Sartorelli A.C., and Randolph G.J. The leukotriene C-4 transporter MRP1 regulates CCL19 (MIP-3 beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103 5 (2000) 757-768
33. Chary S.R., and Jain R.K. Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. Proc Natl Acad Sci U S A 86 (1989) 5385-5389
34. Patel D.D., Koopmann W., Imai T., Whichard L.P., Yoshie O., and Krangel M.S. Chemokines have diverse abilities to form solid phase gradients. Clin Immunol 99 1 (2001) 43-52
35. Boardman K.C., and Swartz M.A. Interstitial flow as a guide for lymphangiogenesis. Circ Res 92 (2003) 801-808
36. Benoit J.N. Effects of f-Met-Leu-Phe-induced inflammation on intestinal lymph flow and lymphatic pump behavior. Am J Physiol 262 2 25-2 (1992) G199-G202
37. Granger D.N., Zimmerman B.J., Sekizuka E., and Grisham M.B. Intestinal microvascular exchange in the rat during luminal perfusion with formyl-methionyl-leucyl-phenylalanine. Gastroenterology 94 3 (1988) 673-681
38. Koizumi T., Kubo K., Hirai K., Shinozaki S., Kobayashi T., Sekiguchi M., et al. Effects of continuous infusion of nitroglycerin on pulmonary hemodynamics, lung lymph balance, and prostanoid products in the response to endotoxin in awake sheep. Lung 171 1 (1993) 19-30
39. Randolph G.J., Angeli V., and Swartz M.A. Dendritic cell trafficking to lymph nodes via lymphatic vessels. Nat Rev Immunol 5 (2005) 1-12
40. Johnson L.A., Clasper S., Holt A.P., Lalor P.F., Baban D., and Jackson D.G. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med 203 12 (2006) 2763-2777
41. Kuroshima S., Sawa Y., Kawamoto T., Yamaoka Y., Notani K., Yoshida S., et al. Expression of Toll-like receptors 2 and 4 on human intestinal lymphatic vessels. Microvasc Res 67 1 (2004) 90-95
42. Wilson N.S., El-Sukkari D., Belz G.T., Smith C.M., Steptoe R.J., Heath W.R., et al. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102 6 (2003) 2187-2194
43. Gatza E., and Okada C.Y. Tumor cell lysate-pulsed dendritic cells are more effective than TCR Id protein vaccines for active immunotherapy of T cell lymphoma. J Immunol 169 9 (2002) 5227-5235
44. Timmerman J.M., Czerwinski D.K., Davis T.A., Hsu F.J., Benike C., Hao Z.M., et al. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood 99 5 (2002) 1517-1526
45. Wang R.F., and Wang H.Y. Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells. Nat Biotech 20 2 (2002) 149-154
46. Harzstark A.L., and Small E.J. Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge). Expert Opin Biol Ther 7 8 (2007) 1275-1280
47. Knutson K.L. Technology evaluation: DCVax, Northwest Biotherapeutics. Curr Opin Mol Ther 4 4 (2002) 403-407
48. Fifis T., Gamvrellis A., Crimeen-Irwin B., Pietersz G.A., Li J., Mottram P.L., et al. Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors. J Immunol 173 5 (2004) 3148-3154
49. Little S.R., Lynn D.M., Ge Q., Anderson D.G., Puram S.V., Chen J., et al. Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc Natl Acad Sci U S A 101 26 (2004) 9534-9539
50. Storni T., Ruedl C., Schwarz K., Schwendener R.A., Renner W.A., and Bachmann M.F. Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects. J Immunol 172 3 (2004) 1777-1785
51. Wang C., Ge Q., Ting D., Nguyen D., Shen H.R., Chen J.Z., et al. Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nat Mater 3 3 (2004) 190-196
52. Bonifaz L.C., Bonnyay D.P., Charalambous A., Darguste D.I., Fujii S., Soares H., et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med 199 6 (2004) 815-824
53. Trumpfheller C., Finke J.S., Lopez C.B., Moran T.M., Moltedo B., Soares H., et al. Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. J Exp Med 203 3 (2006) 607-617
54. Bozzacco L., Trumpfheller C., Siegal F.P., Mehandru S., Markowitz M., Carrington M., et al. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc Natl Acad Sci U S A 104 4 (2007) 1289-1294
55. Kwon Y.J., James E., Shastri N., and Frechet J.M. In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles. Proc Natl Acad Sci U S A 102 51 (2005) 18264-18268
56. van Broekhoven C.L., Parish C.R., Demangel C., Britton W.J., and Altin J.G. Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy. Cancer Res 64 12 (2004) 4357-4365
57. Swartz M.A., and Fleury M.E. Interstitial flow and its effects in soft tissues. Ann Rev Biomed Eng 9 (2007) 229-256
58. Rutkowski J.M., and Swartz M.A. A driving force for change: interstitial flow as a morphoregulator. Trends Cell Biol 17 1 (2007) 44-50
59. Reddy S.T., Berk D.A., Jain R.K., and Swartz M.A. A sensitive in vivo model for quantifying interstitial convective transport of injected macromolecules and nanoparticles. J Appl Physiol 101 (2006) 1162-1169
60. Reddy S.T., Rehor A., Schmoekel H.G., Hubbell J.A., and Swartz M.A. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Cont Rel 112 1 (2006) 26-34
61. Oussoren C., and Storm G. Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev 50 (2001) 143-156
62. Aukland K., and Reed R.K. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Phys Rev 73 1 (1993) 1-78
63. Nishioka Y., and Yoshino H. Lymphatic targeting with nanoparticulate system. Adv Drug Deliv Rev 47 1 (2001) 55-64
64. Hunter R.L. Overview of vaccine adjuvants: present and future. Vaccine 20 Suppl. 3 (2002) S7-S12
65. Salerno-Goncalves R., and Sztein M.B. Cell-mediated immunity and the challenges for vaccine development. Trends Microbiol 14 12 (2006) 536-542
66. Ulevitch R.J. Therapeutics targeting the innate immune system. Nat Rev Immunol 4 7 (2004) 512-520
67. Akira S., and Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4 7 (2004) 499-511
68. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430 6996 (2004) 257-263
69. Mata-Haro V., Cekic C., Martin M., Chilton P.M., Casella C.R., and Mitchell T.C. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316 5831 (2007) 1628-1632
70. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 6813 (2000) 740-745
71. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 6857 (2001) 732-738
72. Vernacchio L., Bernstein H., Pelton S., Allen C., MacDonald K., Dunn J., et al. Effect of monophosphoryl lipid A (MPL) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM197 conjugate vaccine in healthy toddlers. Vaccine 20 31-32 (2002) 3658-3667
73. Little S.R., Lynn D.M., Puram S.V., and Langer R. Formulation and characterization of poly (beta amino ester) microparticles for genetic vaccine delivery. J Cont Rel 107 3 (2005) 449-462
74. Kwon Y.J., Standley S.M., Goh S.L., and Frechet J.M. Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles. J Cont Rel 105 3 (2005) 199-212
75. Dempsey P.W., Allison M.E., Akkaraju S., Goodnow C.C., and Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271 5247 (1996) 348-350
76. Nielsen C.H., Fischer E.M., and Leslie R.G.Q. The role of complement in the acquired immune response. Immunology 100 1 (2000) 4-12
77. Kopf M., Abel B., Gallimore A., Carroll M., and Bachmann M.F. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat Med 8 4 (2002) 373-378
78. Kemper C., and Atkinson J.P. T-cell regulation: with complements from innate immunity. Nat Rev Immunol 7 1 (2007) 9-18
79. Gorbet M.B., and Sefton M.V. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25 26 (2004) 5681-5703
80. Nilsson B., Ekdahl K.N., Mollnes T.E., and Lambris J.D. The role of complement in biomaterial-induced inflammation. Mol Immunol 44 1-3 (2007) 82-94
81. Andersson J., Bexborn F., Klinth J., Nilsson B., and Ekdahl K.N. Surface-attached PEO in the form of activated Pluronic with immobilized factor H reduces both coagulation and complement activation in a whole-blood model. J Biomed Mater Res A 76 1 (2006) 25-34
82. Gorbet M.B., and Sefton M.V. Complement inhibition reduces material-induced leukocyte activation with PEG modified polystyrene beads (Tentagel) but not polystyrene beads. J Biomed Mater Res A 74 4 (2005) 511-522
83. Reddy S.T., van der Vlies A.J., Simeoni E., Angeli V., Randolph G.J., O'Neil C.P., et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 25 10 (2007) 1159-1164
84. Doh J., and Irvine D.J. Immunological synapse arrays: patterned protein surfaces that modulate immunological synapse structure formation in T cells. Proc Natl Acad Sci U S A 103 15 (2006) 5700-5705
85. Irvine D.J., and Doh J. Synthetic surfaces as artificial antigen presenting cells in the study of T cell receptor triggering and immunological synapse formation. Semin Immunol 19 4 (2007) 245-254
86. Stachowiak A.N., and Irvine D.J. Inverse opal hydrogel-collagen composite scaffolds as a supportive microenvironment for immune cell migration. J Biomed Mater Res A (2007) epub ahead of print
87. Suematsu S., and Watanabe T. Generation of a synthetic lymphoid tissue-like organoid in mice. Nat Biotechnol 22 (2004) 1539-1545
88. Okamoto N., Chihara R., Shimizu C., Nishimoto S., and Watanabe T. Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice. J Clin Invest 117 (2007) 997-1007
89. Adams R.H., and Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8 6 (2007) 464-478
90. Liersch R., and Detmar M. Lymphangiogenesis in development and disease. Thromb Haemost 98 2 (2007) 304-310
91. Rutkowski J.M., Boardman K.C., and Swartz M.A. Characterization of lymphangiogenesis in a model of adult skin regeneration. Am J Physiol Heart Circ Physiol 291 (2006) H1402-H1410
92. Goldman J., Conley K.A., Raehl A., Bondy D.M., Pytowski B., Swartz M.A., et al. Regulation of lymphatic capillary regeneration by interstitial flow in skin. Am J Physiol Heart Circ Physiol 292 5 (2007) H2176-H2183
93. Ng C.P., Helm C.E., and Swartz M.A. Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. Microvasc Res 68 3 (2004) 258-264
94. Helm C.E., Fleury M.E., Zisch A.H., Boschetti F., and Swartz M.A. Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. Proc Natl Acad Sci U S A 44 (2007) 15779-15784
95. Helm C.E., Zisch A.H., and Swartz M.A. Engineered blood and lymphatic capillaries in 3D VEGF-fibrin-collagen matrices with interstitial flow. Biotech Bioeng 96 1 (2007) 167-176
96. Goldman J., Rutkowski J.M., Shields J.D., Pasquier M.C., Cui Y., Schmoekel H.G., et al. Cooperative and redundant roles of VEGFR-3 and VEGFR-2 signaling in adult lymphangiogenesis. FASEB J 21 4 (2007) 1003-1012
97. Ehrbar M., Djonov V.G., Schnell C., Tschanz S.A., Martiny-Baron G., Schenk U., et al. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res 94 8 (2004) 1124-1132
98. Fleury M.E., Boardman K.C., and Swartz M.A. Autologous morphogen gradients by subtle interstitial flow and matrix interactions. Biophys J 91 (2006) 113-121
99. Tammela T., He Y., Lyytikkä J., Jeltsch M., Markkanen J., Pajusola K., et al. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins. Circ Res 100 (2007) 1468-1475
100. Slavin S.A., van den Abbeele A.D., Losken A., Swartz M.A., and Jain R.K. Return of lymphatic function after flap transfer for acute lymphedema. Ann Surg 229 (1999) 421-427
101. Rutkowski J.M., Moya M., Johannes J., Goldman J., and Swartz M.A. Secondary lymphedema in the mouse tail: lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. Microvasc Res 72 (2006) 161-171
102. Cheung L., Han J., Beilhack A., Joshi S., Wilburn P., Dua A., et al. An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis. Bio Drugs 20 6 (2006) 363-370
103. Breslin J.W., Gaudreault N., Watson K.D., Reynoso R., Yuan S.Y., and Wu M.H. Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism. Am J Physiol Heart Circ Physiol 293 1 (2007) H709-H718
104. Goldman J., Le T.X., Skobe M., and Swartz M.A. Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin. Circ Res 96 (2005) 1193-1199
105. Yoshida M., and Babensee J.E. Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. J Biomed Mater Res A 71 1 (2004) 45-54
106. Bennewitz N.L., and Babensee J.E. The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen. Biomaterials 26 16 (2005) 2991-2999
107. Zhao X., Jain S., Larman B.H., Gonzalez S., and Irvine D.J. Directed cell migration via chemoattractants released from degradable microspheres. Biomaterials 26 24 (2005) 5048-5063